Medtronic, Ypsomed, and the Diabetes Device Shake-Up: Spin-Offs, Strategy, and the Future of Diabetes Tech
In a transformative moment for diabetes care and medtech strategy, two major players—Medtronic and Ypsomed—have announced spin-offs or divestments of their diabetes divisions. Do these […]